Table 1 Information of 320 vivax malaria cases for amplification of CYP2D6 gene CDSs
Variable | Total (n, F%) | SR group (n, F%) | NR group (n, F%) |
|---|---|---|---|
Total | 320 (100.0) | 63 (19.7) | 257 (80.3) |
1. Gender | |||
 Male | 233 (72.8) | 46 (73.0) | 187 (72.8) |
 Female | 87 (27.2) | 17 (27.0) | 70 (27.2) |
2. Age (in years) | |||
 0–4 | 6 (1.9) | 2 (3.2) | 4 (1.6) |
 5–20 | 36 (11.3) | 3 (4.8) | 33 (12.8) |
 21–60 | 260 (81.2) | 54 (85.7) | 206 (80.2) |
 Above 60 | 18 (5.6) | 4 (6.3) | 14 (5.4) |
3. Malaria relapse | |||
 1 episode | 60 (18.8) | 60 (95.2) | – |
 2 episodes | 2 (0.7) | 2 (3.2) |  |
 3 episodes | 1 (0.3) | 1 (1.6) | – |
4. Infection source a | |||
 Myanmar | 315 (98.4) | 60 (95.2) | 255 (99.2) |
 Africa | 3 (0.9) | 1 (1.6) | 2 (0.8) |
 Yunnan indigenous | 2 (0.7) | 2 (3.2) | – |
5. Days of recurrence (d) | |||
 Shortest | – | 29 | – |
 Median |  | 171 |  |
 Longest | – | 1605 | – |